MeSH term
Frequency | Condition_Probility | Female | 67 | 0.0 |
Humans | 449 | 0.0 |
Pregnancy | 5 | 0.0 |
Animals | 49 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Aged | 31 | 0.0 |
Cardiac Output, Low/*mortality | 3 | 5.0 |
Coronary Arteriosclerosis/mortality | 3 | 5.0 |
Risk | 3 | 0.0 |
Surgical Procedures, Elective/*mortality | 3 | 5.0 |
Time Factors | 23 | 0.0 |
Aged, 80 and over | 13 | 0.0 |
Cells, Cultured | 150 | 0.0 |
Cytokines/biosynthesis | 26 | 4.0 |
Dendritic Cells/drug effects/*immunology | 9 | 34.0 |
English Abstract | 9 | 0.0 |
Flow Cytometry | 102 | 1.0 |
Lipopolysaccharides/*pharmacology | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 322 | 0.0 |
United States | 2 | 0.0 |
Adult | 57 | 0.0 |
Apoptosis | 10 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Count | 11 | 1.0 |
Dendritic Cells/metabolism/*pathology | 2 | 22.0 |
Immunoenzyme Techniques | 6 | 0.0 |
Immunoglobulins/metabolism | 24 | 22.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Male | 49 | 0.0 |
Membrane Glycoproteins/metabolism | 29 | 4.0 |
Middle Aged | 41 | 0.0 |
Prognosis | 3 | 0.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
Antigens, CD14/*immunology | 3 | 6.0 |
CD8-Positive T-Lymphocytes/immunology | 6 | 1.0 |
Cell Adhesion | 9 | 0.0 |
Cell Separation/methods | 5 | 3.0 |
Comparative Study | 54 | 0.0 |
Cytokines/*biosynthesis | 4 | 1.0 |
Cytotoxicity Tests, Immunologic | 6 | 1.0 |
Dendritic Cells/*metabolism | 10 | 16.0 |
Interleukin-10/biosynthesis | 11 | 9.0 |
Interleukin-12/biosynthesis | 26 | 26.0 |
Lipopolysaccharides/pharmacology | 28 | 2.0 |
Monocytes/*immunology | 7 | 1.0 |
Tumor Necrosis Factor-alpha/biosynthesis | 9 | 1.0 |
Adolescent | 16 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Antigens, CD/*analysis | 3 | 0.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
CD4-Positive T-Lymphocytes/*immunology | 2 | 0.0 |
CD8-Positive T-Lymphocytes/*immunology | 3 | 0.0 |
Cell Communication | 5 | 1.0 |
Dendritic Cells | 3 | 20.0 |
Phenotype | 38 | 0.0 |
Antigen-Presenting Cells/*immunology | 5 | 3.0 |
Antigens, CD/*biosynthesis | 4 | 2.0 |
Antigens, CD80/biosynthesis | 8 | 14.0 |
Immunoglobulins/biosynthesis | 18 | 17.0 |
Immunologic Memory | 3 | 1.0 |
Interferon Type II/biosynthesis | 9 | 1.0 |
Interleukin-5/biosynthesis | 2 | 5.0 |
Lymphocyte Activation | 50 | 1.0 |
Lymphocyte Culture Test, Mixed | 60 | 9.0 |
Membrane Glycoproteins/biosynthesis | 20 | 12.0 |
T-Lymphocytes/metabolism | 6 | 2.0 |
Up-Regulation | 22 | 0.0 |
Antigen-Presenting Cells/cytology | 2 | 25.0 |
Antigens, CD34/analysis | 10 | 1.0 |
Cell Differentiation/drug effects | 39 | 3.0 |
Cytokines/*pharmacology | 6 | 1.0 |
Dendritic Cells/*cytology/immunology | 14 | 32.0 |
Hematopoietic Stem Cells/*cytology/immunology | 2 | 2.0 |
Immunoglobulins/analysis | 22 | 8.0 |
Immunophenotyping | 102 | 3.0 |
Membrane Glycoproteins/analysis | 25 | 9.0 |
Models, Biological | 2 | 0.0 |
Antigens, CD/analysis | 34 | 2.0 |
Cell Culture Techniques/methods | 11 | 5.0 |
Immunosuppressive Agents/*pharmacology | 12 | 5.0 |
Monocytes/cytology/drug effects | 3 | 8.0 |
Tacrolimus/*pharmacology | 2 | 5.0 |
Antibodies, Monoclonal | 6 | 0.0 |
Antigen Presentation | 30 | 9.0 |
Antigens, CD40/*immunology | 3 | 7.0 |
Coculture Techniques | 34 | 5.0 |
Cytokines/secretion | 5 | 6.0 |
Dendritic Cells/cytology/drug effects/*immunology | 5 | 22.0 |
In Vitro | 22 | 0.0 |
Peptides/immunology | 3 | 2.0 |
T-Lymphocytes/*immunology | 26 | 1.0 |
T-Lymphocytes, Cytotoxic/immunology | 10 | 2.0 |
Dendritic Cells/*immunology/metabolism | 6 | 13.0 |
Mice | 30 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
*RNA-Binding Proteins | 2 | 0.0 |
Simplexvirus/physiology | 2 | 66.0 |
Solubility | 9 | 0.0 |
T-Lymphocyte Subsets/*immunology | 2 | 0.0 |
Antigens, CD/biosynthesis | 20 | 6.0 |
HLA-DR Antigens/biosynthesis | 12 | 12.0 |
Intercellular Adhesion Molecule-1/biosynthesis | 4 | 4.0 |
Interleukin-8/biosynthesis | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 62 | 0.0 |
Receptors, Cell Surface/*physiology | 4 | 1.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Cell Survival/drug effects | 3 | 0.0 |
Dendritic Cells/cytology/*drug effects/immunology | 7 | 58.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology | 37 | 9.0 |
HLA Antigens/biosynthesis | 2 | 13.0 |
Interleukin-4/pharmacology | 29 | 8.0 |
Plant Extracts/*pharmacology | 2 | 2.0 |
*Plant Proteins | 2 | 3.0 |
Toxins/*pharmacology | 2 | 25.0 |
B-Lymphocytes/immunology | 3 | 0.0 |
Cell Differentiation | 60 | 1.0 |
Cell Line | 16 | 0.0 |
Dendritic Cells/cytology/*immunology | 19 | 32.0 |
Immunotherapy/*methods | 5 | 3.0 |
Dendritic Cells/*immunology | 50 | 20.0 |
Immunization | 4 | 1.0 |
Leukapheresis | 9 | 8.0 |
Membrane Glycoproteins/immunology | 13 | 7.0 |
Peptide Fragments/immunology | 2 | 0.0 |
*Antigen Presentation | 6 | 3.0 |
CD4-Positive T-Lymphocytes/immunology | 10 | 1.0 |
Fetal Blood/cytology/immunology | 2 | 5.0 |
Infant, Newborn | 9 | 0.0 |
Isoantigens/immunology | 4 | 4.0 |
Kinetics | 7 | 0.0 |
Th1 Cells/*immunology | 3 | 2.0 |
Amino Acid Sequence | 8 | 0.0 |
Base Sequence | 8 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
B-Lymphocytes/cytology/immunology | 2 | 6.0 |
Cell Division | 21 | 0.0 |
Cell Survival | 17 | 1.0 |
Monocytes/*cytology | 11 | 13.0 |
Pinocytosis | 2 | 16.0 |
T-Lymphocytes/cytology/immunology | 5 | 7.0 |
Antigens, CD/metabolism | 24 | 2.0 |
Chronic Disease | 4 | 0.0 |
Cytokines/*metabolism | 4 | 1.0 |
Dendritic Cells/*drug effects/immunology/pathology | 2 | 100.0 |
Dose-Response Relationship, Drug | 11 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 11 | 0.0 |
Tumor Necrosis Factor-alpha/analysis | 2 | 0.0 |
Antigens, CD1/analysis | 14 | 18.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 3 | 0.0 |
Biological Markers | 10 | 0.0 |
Immunoglobulins/*analysis | 10 | 10.0 |
Immunohistochemistry | 25 | 0.0 |
Membrane Glycoproteins/*analysis | 10 | 6.0 |
CD40 Ligand/*metabolism | 2 | 14.0 |
Cell Movement | 9 | 1.0 |
Dendritic Cells/*drug effects/metabolism | 2 | 25.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism | 4 | 6.0 |
Protein Conformation | 2 | 0.0 |
Protein Subunits | 2 | 0.0 |
Antigens, Differentiation/metabolism | 2 | 1.0 |
Cytokines/pharmacology | 12 | 3.0 |
Dendritic Cells/*cytology/drug effects/immunology | 3 | 30.0 |
Antigens, CD34 | 8 | 1.0 |
Cell Lineage/immunology | 3 | 10.0 |
Fetus | 2 | 0.0 |
Liver/cytology | 2 | 3.0 |
Mice, SCID | 4 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Adjuvants, Immunologic/*pharmacology | 7 | 4.0 |
Dendritic Cells/*drug effects/physiology | 5 | 41.0 |
Interferon Type II/pharmacology | 4 | 0.0 |
Rats | 2 | 0.0 |
Antigens, Neoplasm/*immunology | 7 | 4.0 |
Cancer Vaccines/*immunology | 3 | 5.0 |
Cytotoxicity, Immunologic | 9 | 0.0 |
Immunotherapy | 3 | 0.0 |
Dendritic Cells/*cytology/*drug effects/immunology | 2 | 40.0 |
Mice, Inbred C3H | 4 | 0.0 |
Mice, Inbred DBA | 2 | 0.0 |
T-Lymphocytes/immunology | 49 | 3.0 |
Tumor Cells, Cultured | 21 | 0.0 |
Antigens, CD14/blood | 2 | 6.0 |
Antigens, CD34/*blood | 2 | 2.0 |
Cell Communication/physiology | 2 | 2.0 |
Cell Differentiation/physiology | 5 | 1.0 |
Cell Division/physiology | 2 | 0.0 |
Dendritic Cells/*cytology/drug effects/metabolism | 2 | 66.0 |
Monocytes/cytology/metabolism | 3 | 11.0 |
Dendritic Cells/*cytology/drug effects/*immunology | 3 | 30.0 |
Fetal Blood/*cytology/drug effects/*immunology | 3 | 75.0 |
Ionophores/pharmacology | 2 | 1.0 |
*Antigens, CD | 5 | 0.0 |
Case-Control Studies | 8 | 0.0 |
Flow Cytometry/methods | 5 | 1.0 |
HLA-DR Antigens/analysis | 15 | 2.0 |
Intestinal Mucosa/*immunology | 2 | 2.0 |
Macrophages/*immunology | 4 | 1.0 |
Statistics, Nonparametric | 3 | 0.0 |
Tumor Necrosis Factor-alpha/immunology | 5 | 4.0 |
Acute Disease | 7 | 0.0 |
Antigens, Differentiation/analysis | 4 | 1.0 |
Cell Lineage | 8 | 1.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Leukemia, Lymphocytic, Acute/*pathology | 2 | 10.0 |
Leukemia, Myeloid/*pathology | 2 | 3.0 |
T-Lymphocyte Subsets/immunology | 5 | 1.0 |
Antibodies/pharmacology | 4 | 1.0 |
Biological Transport | 3 | 0.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Monocytes/cytology/immunology | 7 | 20.0 |
Stem Cells/immunology | 2 | 6.0 |
*Up-Regulation | 3 | 1.0 |
Antigens, CD14/analysis | 13 | 11.0 |
*Cell Communication | 3 | 3.0 |
Spleen/cytology | 3 | 1.0 |
Immunity, Cellular | 5 | 0.0 |
Macaca mulatta | 3 | 0.0 |
Antigens, CD/biosynthesis/genetics | 4 | 11.0 |
Blood Physiology | 2 | 2.0 |
Cattle | 3 | 0.0 |
Chemokines/biosynthesis/genetics | 3 | 16.0 |
Cytokines/biosynthesis/genetics | 2 | 3.0 |
Gene Expression Regulation | 9 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
CD40 Ligand/biosynthesis | 3 | 27.0 |
Cell Differentiation/drug effects/immunology | 19 | 27.0 |
Lymphocyte Activation/drug effects/immunology | 3 | 5.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Monocytes/cytology | 14 | 13.0 |
NF-kappa B/metabolism | 5 | 0.0 |
T-Lymphocytes/*immunology/metabolism | 2 | 1.0 |
Antigens, Neoplasm/immunology | 3 | 2.0 |
Dendritic Cells/*physiology | 20 | 25.0 |
Fetal Blood/*immunology | 2 | 2.0 |
*Immunotherapy | 4 | 2.0 |
*Genetic Vectors | 6 | 1.0 |
Interferon Type II/immunology | 3 | 3.0 |
Interleukin-4/immunology | 7 | 12.0 |
T-Lymphocytes, Cytotoxic/*immunology | 8 | 1.0 |
Transduction, Genetic | 6 | 1.0 |
Dendritic Cells/*immunology/*metabolism | 3 | 17.0 |
Endocytosis | 11 | 2.0 |
*Lectins, C-Type | 8 | 4.0 |
*Mannose-Binding Lectins | 7 | 14.0 |
Monocytes/immunology | 10 | 2.0 |
Protein Binding | 2 | 0.0 |
U937 Cells | 3 | 0.0 |
Cell Division/immunology | 8 | 2.0 |
Lymphocytes, Tumor-Infiltrating/immunology | 3 | 8.0 |
Cell Communication/*immunology | 2 | 4.0 |
Cell Differentiation/immunology | 38 | 11.0 |
Escherichia coli | 2 | 0.0 |
Immunoglobulins/genetics/*immunology | 2 | 66.0 |
Ligands | 10 | 0.0 |
Membrane Glycoproteins/genetics/*immunology | 3 | 5.0 |
Protein Binding/immunology | 4 | 2.0 |
Fetal Blood/cytology | 8 | 4.0 |
Interleukin-10/physiology | 2 | 8.0 |
Vascular Endothelial Growth Factor A | 3 | 0.0 |
Vascular Endothelial Growth Factors | 3 | 0.0 |
Monocytes/*physiology | 5 | 3.0 |
Culture Media, Conditioned | 3 | 0.0 |
Down-Regulation | 6 | 0.0 |
HLA-A2 Antigen/immunology | 2 | 5.0 |
Immunoglobulins | 4 | 16.0 |
Membrane Glycoproteins | 4 | 9.0 |
Phosphoproteins/*immunology | 2 | 16.0 |
Viral Matrix Proteins/*immunology | 2 | 12.0 |
Up-Regulation/immunology | 8 | 5.0 |
Cell Culture Techniques/*methods | 10 | 10.0 |
Dinoprostone/pharmacology | 3 | 3.0 |
Interleukin-13/pharmacology | 2 | 5.0 |
Phagocytosis | 9 | 2.0 |
Recombinant Proteins/pharmacology | 7 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 28 | 2.0 |
Antigens, CD34/blood | 2 | 3.0 |
Culture Media/chemistry/pharmacology | 2 | 18.0 |
Dendritic Cells/*cytology | 15 | 27.0 |
Hematopoietic Stem Cell Mobilization | 3 | 3.0 |
Cell Culture Techniques | 12 | 2.0 |
Dendritic Cells/*immunology/pathology | 3 | 17.0 |
Leukocytes, Mononuclear/immunology | 5 | 1.0 |
Th1 Cells/immunology | 6 | 3.0 |
Antigen Presentation/drug effects | 10 | 32.0 |
Cells, Cultured/drug effects | 2 | 2.0 |
Cytokines/*biosynthesis/genetics | 3 | 4.0 |
Dendritic Cells/cytology/*drug effects/immunology/metabolism | 2 | 66.0 |
Gene Expression Regulation/drug effects | 6 | 0.0 |
Genes, MHC Class II | 3 | 1.0 |
Tumor Necrosis Factor-alpha/biosynthesis/genetics | 4 | 6.0 |
Interferon-alpha/pharmacology | 2 | 2.0 |
Microscopy, Electron, Scanning | 2 | 0.0 |
Receptors, Chemokine/*biosynthesis/genetics | 2 | 6.0 |
Cell Separation/*methods | 5 | 3.0 |
Fetal Blood/*cytology | 5 | 2.0 |
Antigens, CD80/analysis | 4 | 8.0 |
Dendritic Cells/*pathology | 6 | 16.0 |
Histocompatibility Antigens Class II/analysis | 6 | 3.0 |
Intercellular Adhesion Molecule-1/analysis | 3 | 2.0 |
Microscopy, Electron | 11 | 0.0 |
Allergens/*adverse effects | 2 | 18.0 |
Antigens, CD/physiology | 2 | 0.0 |
Lymphocyte Activation/immunology | 23 | 4.0 |
Lymphocytes/immunology | 2 | 0.0 |
Pilot Projects | 3 | 0.0 |
Reference Values | 3 | 0.0 |
Antigen Presentation/immunology | 13 | 16.0 |
Isoantigens | 2 | 7.0 |
Stem Cells/cytology | 2 | 2.0 |
Antigens, CD14/immunology | 4 | 7.0 |
Antigens, CD34/immunology | 4 | 7.0 |
Antigens, CD4/genetics | 2 | 3.0 |
Immunoglobulins/immunology | 10 | 22.0 |
Monocytes/*cytology/drug effects/immunology | 3 | 33.0 |
Receptors, CCR5/genetics | 2 | 3.0 |
Adenoviridae/genetics | 2 | 0.0 |
Monocytes | 3 | 3.0 |
Neoplasms/immunology/*therapy | 2 | 3.0 |
Transfection | 6 | 0.0 |
Chemokines/biosynthesis | 3 | 7.0 |
Th1 Cells/physiology | 2 | 12.0 |
Cytokines/metabolism/pharmacology | 2 | 11.0 |
Dendritic Cells/*immunology/*virology | 2 | 20.0 |
Virus Replication | 6 | 0.0 |
CD40 Ligand/*pharmacology | 3 | 42.0 |
Cell Movement/drug effects | 4 | 1.0 |
*Drosophila Proteins | 3 | 0.0 |
Drug Synergism | 5 | 0.0 |
Interleukin-12/*biosynthesis | 2 | 5.0 |
Membrane Glycoproteins/*biosynthesis | 5 | 5.0 |
Oligodeoxyribonucleotides/*pharmacology | 2 | 6.0 |
Receptors, Cell Surface/*biosynthesis | 3 | 5.0 |
Receptors, Chemokine/biosynthesis | 6 | 12.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Dendritic Cells/*immunology/physiology | 2 | 18.0 |
*Phagocytosis | 2 | 1.0 |
Antigens, Viral/immunology | 2 | 1.0 |
Cell Division/drug effects | 9 | 0.0 |
Child | 6 | 0.0 |
Child, Preschool | 5 | 0.0 |
Leukocytes, Mononuclear/cytology | 3 | 6.0 |
Dendritic Cells/cytology/*immunology/metabolism | 3 | 23.0 |
HLA-DR Antigens/immunology | 7 | 3.0 |
Antigens, CD1/*immunology | 2 | 5.0 |
Skin/cytology/immunology | 2 | 11.0 |
Antigens, CD3/analysis | 3 | 1.0 |
Antigens, CD4/analysis | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
Fluorescent Antibody Technique, Direct | 3 | 2.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Immunotherapy, Adoptive | 4 | 5.0 |
*Lymphocyte Activation | 5 | 0.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 18 | 0.0 |
Stimulation, Chemical | 3 | 0.0 |
Biological Markers/analysis | 4 | 0.0 |
Calcimycin/*pharmacology | 3 | 10.0 |
Calcium/*metabolism | 2 | 0.0 |
Ionophores/*pharmacology | 4 | 20.0 |
Blood | 4 | 2.0 |
Gene Expression Regulation/drug effects/immunology | 2 | 5.0 |
Monocytes/cytology/*drug effects | 2 | 15.0 |
Antigens, CD40/analysis | 2 | 8.0 |
Calcitriol/*pharmacology | 2 | 1.0 |
Cell Differentiation/*drug effects | 6 | 3.0 |
*Cell Differentiation | 3 | 1.0 |
Chemotaxis | 3 | 1.0 |
Dendritic Cells/cytology/immunology/*metabolism | 2 | 28.0 |
Immunoglobulins/immunology/*metabolism | 2 | 40.0 |
Membrane Glycoproteins/immunology/*metabolism | 3 | 7.0 |
Microscopy, Confocal | 5 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Dendritic Cells/*drug effects/immunology | 4 | 28.0 |
Hela Cells | 3 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Antigens, CD14/*metabolism | 4 | 4.0 |
Fetal Blood | 4 | 2.0 |
Interleukin-10/*metabolism | 2 | 6.0 |
Interleukin-4/*metabolism | 2 | 5.0 |
Monocytes/*metabolism | 3 | 0.0 |
Receptors, IgG/*metabolism | 2 | 3.0 |
Tumor Necrosis Factor-alpha/metabolism | 5 | 0.0 |
Lipopolysaccharides/immunology | 4 | 3.0 |
Cell Differentiation/*immunology | 5 | 18.0 |
Endocytosis/immunology | 6 | 27.0 |
Monocytes/cytology/*immunology | 5 | 14.0 |
Receptors, Chemokine/immunology | 4 | 12.0 |
Antigens, CD | 2 | 1.0 |
HLA-DR Antigens | 2 | 0.0 |
Intestinal Mucosa/immunology/pathology | 2 | 10.0 |
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology | 2 | 1.0 |
Dendritic Cells/*drug effects | 5 | 45.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
T-Lymphocytes/drug effects | 2 | 3.0 |
Cytokines/analysis | 3 | 4.0 |
Dendritic Cells/*cytology/physiology | 2 | 40.0 |
Interferon Type I/*pharmacology | 2 | 4.0 |
Dendritic Cells/*cytology/*drug effects/immunology/metabolism | 2 | 100.0 |
Interferon Type II/metabolism | 7 | 3.0 |
Integrin alphaXbeta2/*analysis | 2 | 33.0 |
Antigens, CD13/metabolism | 2 | 22.0 |
HLA-DR Antigens/metabolism | 9 | 6.0 |
Cell Aggregation | 3 | 2.0 |
Fluorescent Antibody Technique | 4 | 0.0 |
Lymph Nodes/*cytology | 2 | 20.0 |
T-Lymphocytes/*physiology | 2 | 0.0 |
Cell Line, Transformed | 3 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Monocytes/drug effects/immunology | 2 | 5.0 |
Interleukin-12/analysis | 4 | 36.0 |
Antigens, CD/*metabolism | 6 | 0.0 |
Calcium/metabolism | 7 | 0.0 |
Down-Regulation/immunology | 7 | 7.0 |
Skin/*immunology | 3 | 2.0 |
Antigens, CD1/metabolism | 6 | 15.0 |
Interferon Type II/secretion | 3 | 2.0 |
K562 Cells | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Receptors, Cell Surface/metabolism | 5 | 1.0 |
Antigens, CD11/analysis | 3 | 10.0 |
Dendritic Cells/*cytology/*immunology | 5 | 33.0 |
Interleukin-12/secretion | 7 | 25.0 |
*Phenotype | 2 | 0.0 |
Antigens, CD1/*analysis | 2 | 9.0 |
Adjuvants, Immunologic/pharmacology | 5 | 5.0 |
Antigens, CD40/biosynthesis | 4 | 14.0 |
Dendritic Cells/*immunology/*metabolism/pathology | 2 | 100.0 |
Dose-Response Relationship, Immunologic | 6 | 1.0 |
Leukocytes, Mononuclear/cytology/immunology | 5 | 11.0 |
Adenoviridae/*genetics | 5 | 2.0 |
Gene Expression | 6 | 0.0 |
Green Fluorescent Proteins | 4 | 0.0 |
Apoptosis/immunology | 4 | 4.0 |
Cytochalasin B/pharmacology | 2 | 2.0 |
Epitopes, T-Lymphocyte/immunology | 3 | 3.0 |
Gene Expression Regulation, Viral/immunology | 2 | 15.0 |
Immunosuppressive Agents/pharmacology | 4 | 2.0 |
Lymphocyte Activation/drug effects | 7 | 1.0 |
Signal Transduction/immunology | 4 | 1.0 |
Antigens, Neoplasm | 2 | 5.0 |
Cell Movement/*immunology | 2 | 2.0 |
Cell Separation | 8 | 0.0 |
Signal Transduction | 3 | 0.0 |
Dendritic Cells/*cytology/*physiology | 2 | 66.0 |
Antibodies, Monoclonal/pharmacology | 4 | 0.0 |
CD40 Ligand/pharmacology | 5 | 19.0 |
Cell Membrane/immunology/metabolism | 2 | 1.0 |
Intracellular Fluid/immunology/metabolism | 2 | 6.0 |
Phosphorylation | 5 | 0.0 |
Tumor Necrosis Factor-alpha/secretion | 2 | 1.0 |
Antigen Presentation/*immunology | 6 | 6.0 |
Antigens, CD34/metabolism | 2 | 0.0 |
Hematopoietic Stem Cells/*immunology | 2 | 1.0 |
Lymphocyte Activation/*immunology | 7 | 1.0 |
Phagocytosis/immunology | 6 | 9.0 |
*Gene Transfer Techniques | 3 | 0.0 |
Genetic Vectors | 5 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
*Transduction, Genetic | 2 | 2.0 |
Cell Adhesion Molecules/biosynthesis | 3 | 3.0 |
Injections, Intradermal | 2 | 4.0 |
T-Lymphocytes/immunology/metabolism | 2 | 1.0 |
*Bacterial Proteins | 2 | 1.0 |
Cell Movement/immunology | 6 | 6.0 |
Dendritic Cells/immunology/pathology | 2 | 10.0 |
Immunity, Natural | 3 | 1.0 |
Receptors, CCR5/biosynthesis | 2 | 5.0 |
Up-Regulation/drug effects/immunology | 3 | 7.0 |
p38 Mitogen-Activated Protein Kinases | 7 | 1.0 |
Dendritic Cells/*cytology/immunology/secretion | 2 | 66.0 |
Antigens, CD/immunology | 12 | 2.0 |
Dendritic Cells/*cytology/*immunology/metabolism | 3 | 27.0 |
Stem Cells/cytology/immunology | 3 | 16.0 |
Antigens, CD14/biosynthesis | 5 | 7.0 |
Antigens, Differentiation, Myelomonocytic/biosynthesis | 2 | 4.0 |
Antigens, Surface/biosynthesis | 5 | 8.0 |
Histocompatibility Antigens Class II/metabolism | 6 | 7.0 |
Interleukin-10/metabolism | 5 | 7.0 |
Antigens, CD14/metabolism | 4 | 3.0 |
Endothelial Growth Factors/pharmacology | 2 | 1.0 |
Lymphokines/pharmacology | 2 | 1.0 |
Culture Media, Conditioned/pharmacology | 4 | 2.0 |
*Apoptosis | 3 | 0.0 |
Culture Media, Serum-Free | 8 | 2.0 |
Capsules | 2 | 4.0 |
Drug Carriers | 2 | 1.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Adjuvants, Immunologic | 2 | 3.0 |
Chemokines/metabolism | 2 | 2.0 |
Cytokines/metabolism | 6 | 1.0 |
Dendritic Cells/immunology/*metabolism | 3 | 17.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
T-Lymphocytes, Cytotoxic/metabolism | 2 | 9.0 |
Histocytochemistry | 3 | 0.0 |
Chemotaxis, Leukocyte/*immunology | 2 | 4.0 |
*Immunophenotyping | 3 | 1.0 |
Antigens, CD80/biosynthesis/genetics | 3 | 60.0 |
Hematopoietic Stem Cells/*cytology/drug effects | 2 | 2.0 |
Immunoglobulins/biosynthesis/genetics | 2 | 66.0 |
Membrane Glycoproteins/biosynthesis/genetics | 3 | 6.0 |
Membrane Proteins/pharmacology | 3 | 6.0 |
Monocytes/*cytology/drug effects | 4 | 25.0 |
Multiple Myeloma/blood | 2 | 13.0 |
Phagocytosis/drug effects | 3 | 3.0 |
Membrane Glycoproteins/*physiology | 3 | 1.0 |
Cyclic AMP/metabolism | 3 | 0.0 |
Cytokines/antagonists & inhibitors/biosynthesis | 2 | 11.0 |
Intracellular Fluid/metabolism | 2 | 1.0 |
Interleukin-6/biosynthesis | 5 | 2.0 |
Antigens, CD40/immunology | 5 | 9.0 |
Antigens, CD/analysis/immunology | 2 | 4.0 |
Staining and Labeling/methods | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Antigens, CD80/metabolism | 5 | 6.0 |
Interleukin-4/metabolism | 7 | 7.0 |
Lentivirus/*genetics | 2 | 5.0 |
Leukocytes, Mononuclear/metabolism | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Transgenes | 2 | 0.0 |
Antigens, CD1/biosynthesis | 4 | 25.0 |
Stem Cell Factor/pharmacology | 3 | 2.0 |
Transforming Growth Factor beta/pharmacology | 3 | 0.0 |
CD40 Ligand/immunology | 3 | 27.0 |
Chemokines, CC/metabolism | 3 | 6.0 |
Gene Expression/drug effects | 2 | 0.0 |
*Macrophage Inflammatory Proteins | 3 | 18.0 |
Up-Regulation/drug effects | 4 | 1.0 |
CD4-Positive T-Lymphocytes/virology | 2 | 2.0 |
Tumor Necrosis Factor-alpha/physiology | 2 | 1.0 |
Antigens, CD40/metabolism | 5 | 7.0 |
Hemocyanin/pharmacology | 2 | 33.0 |
Molecular Weight | 3 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Dendritic Cells/drug effects/*immunology/metabolism | 3 | 50.0 |
Sodium Dodecyl Sulfate/pharmacology | 2 | 8.0 |
*Cancer Vaccines | 2 | 7.0 |
Epitopes/genetics | 2 | 2.0 |
Liposomes | 2 | 0.0 |
Transfection/*methods | 2 | 3.0 |
Interferon Type II/analysis | 2 | 2.0 |
Interleukin-2/analysis | 3 | 7.0 |
Dextrans | 2 | 4.0 |
Dendritic Cells/*cytology/immunology/physiology | 3 | 75.0 |
Hematopoietic Stem Cells/cytology | 3 | 3.0 |
*Immunoconjugates | 2 | 0.0 |
Antigens, CD80/immunology | 3 | 4.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/immunology | 4 | 14.0 |
Lymphocytes/cytology | 3 | 3.0 |
COS Cells | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
Electroporation | 2 | 3.0 |
Mice, Inbred BALB C | 4 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Ovalbumin/immunology | 3 | 6.0 |
Drug Combinations | 3 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Arthritis, Rheumatoid/*immunology | 2 | 0.0 |
Receptors, Tumor Necrosis Factor, Type I | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*antagonists & inhibitors/physiology | 2 | 11.0 |
Interleukin-10/pharmacology | 2 | 2.0 |
CD40 Ligand | 8 | 4.0 |
Calcineurin/*antagonists & inhibitors | 2 | 15.0 |
Cyclosporine/*pharmacology | 3 | 2.0 |
Dexamethasone/*pharmacology | 4 | 1.0 |
Glucocorticoids/*pharmacology | 2 | 1.0 |
Membrane Glycoproteins/genetics/metabolism | 2 | 2.0 |
Monocytes/cytology/drug effects/immunology | 3 | 30.0 |
T-Lymphocytes/drug effects/immunology | 3 | 3.0 |
DNA Primers/chemistry | 2 | 0.0 |
Monocytes/*cytology/drug effects/metabolism | 2 | 33.0 |
Recombinant Proteins/immunology | 4 | 1.0 |
Mitogen-Activated Protein Kinases/*physiology | 2 | 2.0 |
*Signal Transduction | 3 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Killer Cells, Natural/*immunology | 4 | 0.0 |
Macrophages/immunology | 3 | 1.0 |
Phagocytosis/*immunology | 2 | 3.0 |
Transcription, Genetic | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 5 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Lipopolysaccharides/metabolism | 2 | 1.0 |
Membrane Glycoproteins/analysis/metabolism | 2 | 15.0 |
Picibanil/*pharmacology | 3 | 17.0 |
Vaccination/methods | 2 | 16.0 |
Antigens, CD/analysis/metabolism | 2 | 14.0 |
Dendritic Cells/*drug effects/immunology/metabolism | 2 | 33.0 |
Interleukin-12/metabolism | 10 | 19.0 |
Histocompatibility Antigens Class II/immunology | 4 | 2.0 |
Neoplasm Metastasis | 2 | 0.0 |
Cyclosporine/pharmacology | 2 | 0.0 |
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology | 5 | 3.0 |
Immunoglobulins/*immunology | 5 | 17.0 |
Membrane Glycoproteins/*immunology | 5 | 2.0 |
Interleukin-6/metabolism | 2 | 0.0 |
Protein Subunits/metabolism | 2 | 4.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Helicobacter pylori/*immunology | 2 | 10.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Antigens/metabolism | 3 | 4.0 |
Dendritic Cells/cytology/*drug effects/*immunology/metabolism | 2 | 50.0 |
Immune Tolerance/drug effects | 2 | 7.0 |
Culture Media | 9 | 1.0 |
Dendritic Cells/*cytology/drug effects | 2 | 100.0 |
Immunomagnetic Separation | 4 | 3.0 |
Leukocytes, Mononuclear | 3 | 6.0 |
HIV-1/*immunology | 5 | 1.0 |
Interleukin-10/secretion | 2 | 6.0 |
Lymphocyte Activation/*drug effects | 2 | 0.0 |
Dendritic Cells/*immunology/*pathology | 2 | 40.0 |
Dendritic Cells/chemistry/*immunology | 2 | 50.0 |
Cell Death | 3 | 0.0 |
Necrosis | 3 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Interleukin-12/metabolism/secretion | 2 | 50.0 |
Receptors, Cell Surface/immunology/metabolism | 2 | 13.0 |
Inflammation | 3 | 0.0 |
*Down-Regulation | 3 | 0.0 |
Interleukin-4/*metabolism/pharmacology | 2 | 33.0 |
5'-Nucleotidase/*metabolism | 2 | 22.0 |
Adenosine Monophosphate/metabolism | 2 | 18.0 |
Adenosine Triphosphate/metabolism/pharmacology | 2 | 18.0 |
Antigens, Surface/immunology | 5 | 2.0 |
Dendritic Cells/*enzymology | 2 | 28.0 |
Fura-2 | 2 | 7.0 |
Receptors, Purinergic P2/genetics/*metabolism | 2 | 100.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Dendritic Cells/cytology/*metabolism | 3 | 27.0 |
*Receptors, Chemokine | 2 | 2.0 |
Tumor Necrosis Factor-alpha/biosynthesis/secretion | 2 | 28.0 |
Macrophages/cytology | 2 | 2.0 |
Dextrans/pharmacokinetics | 2 | 40.0 |
Receptors, Cell Surface/*metabolism | 3 | 0.0 |
Antigens, CD/blood | 2 | 0.0 |
Antigen-Presenting Cells/immunology | 3 | 1.0 |
Tumor Necrosis Factor-alpha/*physiology | 2 | 0.0 |
Clone Cells | 3 | 0.0 |
Cell Adhesion/immunology | 4 | 2.0 |
Cell Communication/immunology | 2 | 2.0 |
Langerhans Cells/immunology | 2 | 5.0 |
Membrane Glycoproteins/pharmacology | 3 | 5.0 |
Mycobacterium bovis/*immunology | 2 | 10.0 |
Immune Tolerance | 4 | 1.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Immunotherapy, Adoptive/methods | 2 | 16.0 |
Intercellular Adhesion Molecule-1/immunology | 2 | 4.0 |
Leukapheresis/methods | 2 | 12.0 |
Cell Differentiation/*drug effects/immunology | 2 | 50.0 |
Enzyme Inhibitors/pharmacology | 5 | 0.0 |
Killer Cells, Natural/immunology | 2 | 0.0 |
Antigens, Surface/*immunology | 3 | 1.0 |
Antigens, CD40/*genetics | 2 | 50.0 |
Dendritic Cells/cytology/*immunology/*metabolism | 4 | 36.0 |
Organ Specificity | 2 | 0.0 |
Dendritic Cells/*immunology/virology | 3 | 33.0 |
Enzyme Activation/immunology | 2 | 1.0 |
Recombination, Genetic | 3 | 0.0 |
Dendritic Cells/*classification | 2 | 50.0 |
Cell Membrane/immunology | 2 | 0.0 |
Leukocyte Count | 4 | 0.0 |
Cryopreservation | 3 | 2.0 |
CD40 Ligand/immunology/pharmacology | 2 | 66.0 |
Lipopolysaccharides/immunology/pharmacology | 2 | 9.0 |
Antigens, Surface/*analysis | 2 | 1.0 |
Lymphocyte Activation/genetics | 2 | 2.0 |
T-Lymphocytes/cytology/*immunology | 4 | 3.0 |
Species Specificity | 2 | 0.0 |
Fetal Blood/cytology/*immunology | 2 | 10.0 |
Antigens, CD40/*metabolism | 2 | 4.0 |
Antigens, CD11c/analysis | 2 | 20.0 |
*Antigens, CD34 | 2 | 2.0 |
Cell Size | 2 | 0.0 |
Inflammation/pathology | 2 | 3.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 5 | 0.0 |
Dendritic Cells/immunology/*pathology | 4 | 26.0 |
Interleukin-4/*pharmacology | 2 | 0.0 |
Hematopoietic Stem Cells/*cytology | 3 | 1.0 |
Dendritic Cells/*cytology/immunology/metabolism | 2 | 25.0 |
Dinoprostone/*pharmacology | 2 | 3.0 |
Endocytosis/drug effects | 3 | 4.0 |
Cell Differentiation/*physiology | 2 | 0.0 |
Antigens, CD45/analysis | 3 | 1.0 |
Antigens, CD80/*analysis | 2 | 13.0 |
Drug Evaluation, Preclinical | 2 | 1.0 |
Interleukin-10/*biosynthesis | 2 | 3.0 |
Immunoglobulins/*metabolism | 5 | 9.0 |
Interleukin-12/*metabolism | 2 | 15.0 |
Membrane Glycoproteins/*metabolism | 5 | 1.0 |
Monocytes/physiology | 3 | 2.0 |
Chemokines, CC/physiology | 2 | 15.0 |
Dendritic Cells/immunology | 4 | 2.0 |
Endotoxins/pharmacology | 2 | 2.0 |
Glucocorticoids/pharmacology | 2 | 1.0 |
Neutrophils/immunology | 2 | 1.0 |
Dendritic Cells/cytology/*drug effects/*immunology | 2 | 33.0 |
Immunotherapy/methods | 3 | 3.0 |
Lymphocyte Activation/*physiology | 2 | 2.0 |
Microscopy, Phase-Contrast | 2 | 2.0 |
Tumor Necrosis Factor-alpha/*metabolism | 3 | 0.0 |
*Dendritic Cells | 2 | 18.0 |
Organ Culture Techniques | 2 | 0.0 |
Cell Division/drug effects/immunology | 2 | 3.0 |
Leukocytes, Mononuclear/*immunology | 2 | 1.0 |
Feasibility Studies | 2 | 0.0 |
Flavonoids/pharmacology | 3 | 0.0 |
Imidazoles/pharmacology | 2 | 0.0 |
Pyridines/pharmacology | 2 | 0.0 |
Cell Proliferation/drug effects | 2 | 2.0 |
Clonal Anergy/immunology | 2 | 14.0 |
Interleukins/pharmacology | 2 | 2.0 |
Lectins, C-Type/metabolism | 3 | 20.0 |
Gene Expression Regulation/immunology | 2 | 1.0 |
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use | 2 | 0.0 |
Granulocyte Colony-Stimulating Factor/*therapeutic use | 2 | 3.0 |
Cytokines/immunology/metabolism | 2 | 9.0 |
Antigens, Surface/metabolism | 2 | 1.0 |
Signal Transduction/drug effects/immunology | 2 | 4.0 |
T-Lymphocytes/drug effects/*immunology | 3 | 2.0 |
Chemokines/*metabolism | 2 | 3.0 |
Dendritic Cells/drug effects/*physiology | 2 | 25.0 |
Interleukin-2/metabolism | 2 | 1.0 |
Protein Subunits/biosynthesis | 2 | 15.0 |
Monocytes/cytology/immunology/metabolism | 2 | 14.0 |
Mutation | 2 | 0.0 |
Osmolar Concentration | 2 | 0.0 |
Mannose-Binding Lectins/metabolism | 2 | 33.0 |
Epithelium/immunology | 2 | 1.0 |
Lymphocyte Count | 2 | 0.0 |
Herpesvirus 1, Human/immunology | 2 | 28.0 |
Interferon-alpha/secretion | 2 | 50.0 |
Fetal Blood/immunology | 2 | 2.0 |
Interleukin-12/biosynthesis/secretion | 2 | 66.0 |
Gene Therapy | 2 | 0.0 |
Antigens, CD/biosynthesis/immunology | 2 | 7.0 |
HLA-DR Antigens/biosynthesis/immunology | 2 | 40.0 |
Membrane Glycoproteins/genetics/*metabolism | 2 | 1.0 |
Cell Cycle | 2 | 0.0 |
Antigens, CD/immunology/metabolism | 2 | 3.0 |
Cell Aging | 2 | 2.0 |
Dendritic Cells/*drug effects/*physiology | 2 | 66.0 |
Indicators and Reagents | 2 | 0.0 |
I-kappa B/metabolism | 2 | 2.0 |
Cell Adhesion Molecules/*metabolism | 2 | 0.0 |
Mycobacterium bovis/immunology | 2 | 8.0 |
Histocompatibility Antigens Class II/biosynthesis | 2 | 4.0 |
